Drugs for Diaphragmatic Hernia, Congenital (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 36)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Nitric Oxide |
Approved |
Phase 4 |
|
10102-43-9 |
145068 |
Synonyms:
(.)NO
(NO)(.)
[NO]
EDRF
Endogenous nitrate vasodilator
Endothelium-derived nitric oxide
Endothelium-derived relaxing factor
HYDROXYAMINE
INOmax
INOmax®|nitric oxide|nitrogen monoxide
Mononitrogen monoxide
Monoxide, mononitrogen
Monoxide, nitrogen
Monoxido de nitrogeno
Monóxido de nitrógeno
Monoxyde d'azote
Nitrate vasodilator, endogenous
NITRIC OXIDE
Nitric oxide, endothelium derived
Nitric oxide, endothelium-derived
Nitrogen monooxide
|
Nitrogen monoxide
Nitrogen oxide
Nitrogen protoxide
Nitrosyl
Nitrosyl hydride
Nitrosyl radical
Nitroxide radical
Nitroxyl
NO
NO(.)
OHM-11771
Oxide, nitric
Oxido de nitrogeno(II)
óxido de nitrógeno(II)
Oxido nitrico
óxido nítrico
Oxyde azotique
Oxyde nitrique
Stickstoff(II)-oxid
Stickstoffmonoxid
Vasodilator, endogenous nitrate
|
|
2 |
|
Sodium citrate |
Approved, Investigational |
Phase 4 |
|
68-04-2 |
23431961 |
Synonyms:
Anhydrous sodium citrate
Anhydrous trisodium citrate
Citric acid, trisodium salt
Natrii citras
Natrocitral
Sodium citrate anhydrous
Sodium citrate, anhydrous
|
Sodium citrate,anhydrous
Sodium citric acid
Trisodium 2-hydroxypropane-1,2,3-tricarboxylate
trisodium citrate anhydrous
Trisodium citrate, anhydrous
Trisodium-citrate
|
|
3 |
|
Sildenafil |
Approved, Investigational |
Phase 4 |
|
139755-83-2, 171599-83-0 |
5212 135398744 |
Synonyms:
1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine
1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulphonyl)-4-methylpiperazine
1-((3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-D)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine citrate
1-{[3-(4,7-DIHYDRO-1-METHYL-7-OXO-3-PROPYL-1H-PYRAZOLO[4,3-D]PYRIMIDIN-5-YL)-4-ETHOXYPHENYL]SULFONYL}-4-METHYLPIPERAZINE
5-[2-ETHOXY-5-(4-METHYLPIPERAZIN-1-YLSULFONYL)PHENYL]-1-METHYL-3-PROPYL-1H-PYRAZOLO[4,3-D]PYRIMIDIN-7(6H)-ONE
5-[2-ETHOXY-5-(4-METHYL-PIPERAZINE-1-SULFONYL)-PHENYL]-1-METHYL-3-PROPYL-1,6-DIHYDRO-PYRAZOLO[4,3-D]PYRIMIDIN-7-ONE
Acetildenafil
Aphrodil
Caverta
Citrate, sildenafil
Desmethyl sildenafil
Desmethylsildenafil
HIP0908
HIP-0908
Homosildenafil
Hydroxyhomosildenafil
Lactate, sildenafil
NCX 911
|
NCX-911
NIPATRA
Nitrate, sildenafil
Revatio
Sildenafil
Sildenafil citrate
Sildenafil lactate
Sildenafil nitrate
Sildenafil Viagra
Sildenafil, desmethyl
Sildenafilo
UK-92480
UK-9248010
UK-92480-10
Viagra
Viagra®
VIZARSIN
|
|
4 |
|
Citric acid |
Approved, Nutraceutical, Vet_approved |
Phase 4 |
|
77-92-9 |
311 |
Synonyms:
2-hydroxy-1,2,3-propanetricarboxyic acid
2-Hydroxy-1,2,3-propanetricarboxylate
2-Hydroxy-1,2,3-propanetricarboxylic acid
2-Hydroxytricarballylate
2-Hydroxytricarballylic acid
3-Carboxy-3-hydroxypentane-1,5-dioate
3-Carboxy-3-hydroxypentane-1,5-dioic acid
Acid monohydrate, citric
ácido cítrico
Acidum citricum
Aciletten
Anhydrous citrate
Anhydrous citric acid
beta-Hydroxytricarballylate
beta-Hydroxytricarballylic acid
Chemfill
Citraclean
Citrate
Citrate anhydrous
Citretten
CITRIC ACID
Citric acid anhydrous
CITRIC ACID HYDRATE
Citric acid monoglyceride
|
Citric acid monohydrate
Citric acid, anhydrous
Citric acid,anhydrous
Citro
Citronensaeure
Citronensäure
e 330
e330
E-330
FEMA NO. 2306
H3Cit
Hydrocerol a
INS NO.330
INS-330
Kyselina citronova
Monohydrate, citric acid
NSC-112226
NSC-30279
NSC-626579
Suby g
Uralyt u
UROLOGIC G
Uro-trainer
|
|
5 |
|
Protective Agents |
|
Phase 4 |
|
|
|
6 |
|
Bronchodilator Agents |
|
Phase 4 |
|
|
|
7 |
|
Anti-Asthmatic Agents |
|
Phase 4 |
|
|
|
8 |
|
Respiratory System Agents |
|
Phase 4 |
|
|
|
9 |
|
Neurotransmitter Agents |
|
Phase 4 |
|
|
|
10 |
|
Endothelium-Dependent Relaxing Factors |
|
Phase 4 |
|
|
|
11 |
|
Antioxidants |
|
Phase 4 |
|
|
|
12 |
|
Phosphodiesterase Inhibitors |
|
Phase 4 |
|
|
|
13 |
|
Vasodilator Agents |
|
Phase 4 |
|
|
|
14 |
|
Phosphodiesterase 5 Inhibitors |
|
Phase 4 |
|
|
|
15 |
|
Citrate |
|
Phase 4 |
|
|
|
16 |
|
Esomeprazole |
Approved, Investigational, Vet_approved |
Phase 3 |
|
73590-58-6, 119141-88-7 |
9568614 4594 |
Synonyms:
( -)-Omeprazole
(−)-omeprazole
(-)-Omeprazole
(S)-(−)-omeprazole
(S)-(-)-Omeprazole
(S)-5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole
(S)-5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-1H-benzimidazole
(S)-Omeprazole
(S)-omeprazole|Nexium®
2,3,5-Trimethylpyridine/Omeprazole
A02BC05
Alenia
Antra
Antra mups
AstraZeneca brand OF esomeprazole magnesium
Audazol
Aulcer
Axagon
Belmazol
Ceprandal
Danlox
Demeprazol
Desec
Dizprazol
Dudencer
Elgam
Emeproton
EMOZUL
Epirazole
Erbolin
Escz
Esofag
Esomeprazol
Esomeprazole
Ésoméprazole
Esomeprazole magnesium
Esomeprazole potassium
Esomeprazole sodium
Esomeprazole strontium
Esomeprazole strontium anhydrous
Esomeprazolum
Esomperazole
Esopral
Exter
Gasec
Gastrimut
Gastroloc
Gibancer
H 168/68
H 168/68|Losec®|Prilosec®
H-168/68
Indurgan
Inexium paranova
Inhibitron
Inhipump
Lensor
Logastric
Lomac
Losec
LOSEC MUPS
Lucen
Magnesium, omeprazole
Mepral
MEZZOPRAM
Miol
Miracid
Mopral
Morecon
Nexiam
Nexium
NEXIUM CONTROL
NEXIUM I.V.
Nexium IV
Nilsec
Nopramin
|
Nuclosina
Ocid
Olexin
Omapren
Omebeta 20
Omed
Omegast
OMEP
Omepradex
Omepral
Omeprazol
Omeprazol [INN-Spanish]
Omeprazole
Omeprazole magnesium
Omeprazole pellets
Omeprazole S-form
Omeprazole sodium
Omeprazolum
Omeprazolum [INN-Latin]
Omeprazon
Omeprol
OMERAN
Omesek
Omez
Omezol
Omezolan
Omid
Omisec
Omizac
OMP
Ompanyt
OMZ
Ortanol
Osiren
Ozoken
Paprazol
Parizac
Pepticum
Pepticus
Peptilcer
Perprazole
Prazentol
Prazidec
Prazolit
Prestwick_808
Prilosec
Prilosec otc
Procelac
Proclor
Prysma
Ramezol
Regulacid
Result
Sanamidol
Secrepina
Sodium, omeprazole
Strontium, esomeprazole
Tedec ulceral
Ulceral
Ulcesep
Ulcometion
Ulcozol
Ulcsep
Ulsen
Ultop
Ulzol
VENTRA
Victrix
ZANPROL
Zefxon
Zegerid
Zepral
Zimor
Zoltum
|
|
17 |
|
Anti-Ulcer Agents |
|
Phase 3 |
|
|
|
18 |
|
Antacids |
|
Phase 3 |
|
|
|
19 |
|
Proton Pump Inhibitors |
|
Phase 3 |
|
|
|
20 |
|
Gastrointestinal Agents |
|
Phase 3 |
|
|
|
21 |
|
Milrinone |
Approved |
Phase 2 |
|
78415-72-2 |
4197 |
Synonyms:
1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile
Corotrop
Corotrope
Lactate, milrinone
Milrila
Milrinona
Milrinone
Milrinone lactate
milrinone lactate|Primacor®
|
Milrinonum
Primacor
Sanofi brand OF milrinone lactate
Sanofi synthelabo brand OF milrinone
Sanofi synthelabo brand OF milrinone lactate
Sanofi winthrop brand OF milrinone lactate
WIN-472032
WIN-47203-2
|
|
22 |
|
Anesthetics |
|
Phase 2 |
|
|
|
23 |
|
Cardiotonic Agents |
|
Phase 2 |
|
|
|
24 |
|
Phosphodiesterase 3 Inhibitors |
|
Phase 2 |
|
|
|
25 |
|
Platelet Aggregation Inhibitors |
|
Phase 2 |
|
|
|
26 |
|
Benzocaine |
Approved, Investigational |
|
|
1994-09-7, 94-09-7 |
2337 |
Synonyms:
(P-(Ethoxycarbonyl)phenylamine
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-Aminobenzoate
4-Aminobenzoate ethyl ester
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Carbethoxyaniline
Acetate, benzocaine
Aethoform
AEZODENT
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthin
Anestezin
Anesthesin
Anesthesine
Anesthone
ANTHISAN PLUS
AR01
AR-01
Baby anbesol
Bensokain
Benzoak
Benzocaina
BENZOCAINE
Benzocaine acetate
Benzocaine formate
Benzocaine hydrobromide
Benzocaine hydrochloride
Benzocaine methanesulfonate
Benzocainum
BURNEZE
CHILDREN'S CHLORASEPTIC
DEQUACAINE
Dermoplast
Diet ayds
Ethoform
Ethyl 4-aminobenzoate
|
Ethyl 4-aminobenzoic acid
Ethyl aminobenzoate
Ethyl aminobenzoic acid
Ethyl P-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethyl p-aminophenylcarboxylic acid
Ethylester kyseliny P-aminobenzoove
Formate, benzocaine
Hurricaine
Hydrobromide, benzocaine
Hydrochloride, benzocaine
Identhesin
Keloform
LANACANE
MEDILAVE
Methanesulfonate, benzocaine
NESTOSYL
Norcain
Norcaine
NSC-41531
NSC-4688
Orabase-b
Ora-jel
ORAJEL
Orthesin
p-(Ethoxycarbonyl)aniline
P-Aminobenzoate
P-Aminobenzoic acid
P-Aminobenzoic acid ethyl ester
Parathesin
Parathesine
p-Carbethoxyaniline
p-Ethoxycarboxylic aniline
Slim mint gum
Solarcaine
Solu H
Topcaine
TYROSOLVEN
TYROZETS
|
|
27 |
|
Tannic acid |
Approved |
|
|
1401-55-4 |
16129878 16129778 |
Synonyms:
Acid, tannic
ácido tánico
Acids, tannic
E181
FEMA NO. 3042
Gallotannic acid
|
Gallotannin
NSC-656273
TANNIC ACID
Tannic acids
Tannins
|
|
28 |
|
Fentanyl |
Approved, Illicit, Investigational, Vet_approved |
|
|
437-38-7 |
3345 |
Synonyms:
1-Phenethyl-4-(N-phenylpropionamido)piperidine
1-Phenethyl-4-N-propionylanilinopiperidine
ABSTRAL
Abstral®|Actiq®|Durogesic®|Effentora®|MCN-JR-4263-49|R-4263|Sublimaze®
ACTIQ
AD 923
AD-923
BREAKYL
Cephalon brand OF fentanyl buccal oravescent
Duragesic
DURAGESIC-100
DURAGESIC-12
DURAGESIC-25
DURAGESIC-37
DURAGESIC-50
DURAGESIC-75
Durogesic
DUROGESIC DTRANS
EFFENTORA
FENCINO
FENTALIS RESERVOIR
Fentanest
Fentanil
Fentanila
Fentanila [INN-Spanish]
Fentanilo
Fentanyl
Fentanyl CII
Fentanyl citrate
FENTANYL-100
FENTANYL-12
FENTANYL-25
FENTANYL-37
FENTANYL-50
FENTANYL-62
FENTANYL-75
FENTANYL-87
Fentanylum
|
Fentanylum [INN-Latin]
Fentora
IDS-NF-001
INNOVAR
IONSYS
Janssen pharmaceutica brand OF fentanyl
LEPTANAL
MATRIFEN
MCN-JR-4263-49
MEZOLAR MATRIX
MYLAFENT
N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide
N-(1-Phenethyl-4-piperidyl)propionanilide
N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide
N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide
N02AB03
Nasalfent
N-Phenethyl-4-(N-propionylanilino)piperidine
N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide
OPIODUR
ORALET
OSMACH
OSMANIL
PECFENT
Pentanyl
Phentanyl
R 4263
R-4263
Rapinyl
RECIVIT
Sentonil
Sublimaze
Subsys
TILOFYL
Transmucosal oral fentanyl citrate
VICTANYL
YEMEX
|
|
29 |
|
Atropine |
Approved, Vet_approved |
|
|
101-31-5, 5908-99-6, 51-55-8 |
3661 154417 174174 |
Synonyms:
(-)-Atropine
(−)-ATROPINE
(-)-Hyoscyamine
(−)-HYOSCYAMINE
(±)-atropine
(±)-hyoscyamine
(Leo)-atropine
(Leo)-hyoscyamine
(S)-(-)-Hyoscyamine
(S)-(−)-HYOSCYAMINE
(S)-(Leo)-hyoscyamine
(S)Atropine
(S)-ATROPINE
[3(S)-endo]-a-(Hydroxymethyl)benzeneacetate 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester
[3(S)-endo]-a-(Hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester
[3(S)-endo]-alpha-(Hydroxymethyl)benzeneacetate 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester
[3(S)-endo]-alpha-(Hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester
[3(S)-endo]-Α-(hydroxymethyl)benzeneacetate 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester
[3(S)-endo]-Α-(hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester
Anaspaz
ATROJECT
ATROPEN
Atropen®|hyoscyamine
ATROPHATE
Atropin
Atropina
ATROPINE
ATROPINE (AUTOINJECTOR)
Atropine sulfate, 3(S)-endo-isomer
Atropine, 3(S)-endo-isomer
Atropinum
BUWECON
CYSTOSPAZ
Cytospaz
|
DATURIN
Daturine
dl-Hyoscyamine
dl-tropyltropate
DONNAMAR
Duboisine
EGAZIL
Hyocyamine
HYOMAX
HYOSCYAMIN
Hyoscyamine
Hyoscyamine hydrobromide
Hyoscyamine hydrochloride
Hyoscyamine sulfate
Hyoscyamine sulfate anhydrous
HYOSCYAMINUM
ISOPTO ATROPINE
L-Atropine
LEVBID
LEVSIN
LEVSINEX
L-Hyopscyamine
L-Hyoscamine
L-Hyoscyamine
L-Tropine tropate
L-Tropine tropic acid
NEOQUESS
NULEV
SPACOL T/S
SYMAX
Tropine tropate
Tropine, (-)-tropate
Tropine, (-)-tropic acid
TROPINE-L-TROPATE
|
|
30 |
|
Salbutamol |
Approved, Vet_approved |
|
|
18559-94-9 |
2083 |
Synonyms:
(±)-SALBUTAMOL
(L)-Albuterol
1-(Tert-butylaminomethyl)-4-hydroxy-m-xylene-alpha1,alpha3-diol
2-(Tert-butylamino)-1-(4-hydroxy-3-hydroxymethylphenyl)ethanol
2-t-Butylamino-1-(4-hydroxy-3-hydroxy-3-hydroxymethyl)phenylethanol
4-Hydroxy-3-hydroxymethyl-alpha-((tert-butylamino)methyl)benzyl alcohol
ACCUNEB
Aerolin
AEROLIN 400
AEROLIN AUTO
AIROMIR
AIRSALB
Albuterol
Albuterol sulfate
Albuterol Sulphate
albuterol|SCH-13949W|Ventolin®
Almotex
Alpha'-((tert-butylamino)methyl)-4-hydroxy-m-xylene-alpha,alpha'-diol
Alti-salbutamol
Anebron
Arubendol-salbutamol
Asmadil
Asmanil
Asmasal
ASMASAL CLICKHALER
ASMASAL SPACEHALER
Asmatol
Asmaven
ASMAVENT
Asmidon
Asmol
Asmol uni-dose
Asthalin
Asthavent
Broncho-spray
Broncovaleas
Bronter
BTA204
Bugonol
Bumol
Butamol
Buto-asma
Butohaler
Butotal
Butovent
Buventol
Cetsim
Cobutolin
COMBIVENT
COMBIVENT UDVS
Dilatamol
DL-Albuterol
DL-N-Tert-butyl-2-(4-hydroxy-3-hydroxymethylphenyl)-2-hydroxyethylamine
DL-Salbutamol
DUONEB
Ecovent
Farcolin
Gerivent
Grafalin
IPRAMOL STERI-NEB
KENTAMOL
Levalbuterol
LIBETIST
Libretin
Loftan
MAXIVENT
Medolin
Mozal
Novosalmol
Parasma
Pneumolat
ProAir
PROAIR HFA
Proventil
|
Proventil hfa
Proventil inhaler
PROVENTIL-HFA
Respax
Respolin
RIMASAL
Rotahaler
R-Salbutamol
Sabutal
Salamol
SALAMOL E-BREATHE
SALAPIN
Salbetol
Salbron
Salbu-basf
Salbu-fatol
Salbuhexal
Salbulin
SALBULIN NOVOLIZER
Salbupur
Salbusian
Salbutalan
SALBUTAMOL
Salbutamol free base
Salbutamol sulfate
Salbutamol sulphate
Salbutamolum
Salbutan
Salbutard
Salbutine
Salbutol
Salbuven
Salbuvent
SALIPRANEB
Sallbupp
Salmaplon
Salomol
Salvent
Saventol
SCH 13949W
SCH-13949W
Servitamol
Solbutamol
Spreor
STERI-NEB SALAMOL
Sultanol
Sultanol N
Suprasma
Suxar
Theosal
Tobybron
Vencronyl
Venetlin
Ventalin Inhaler
Ventamol
Ventilan
Ventiloboi
VENTMAX SR
Ventodisks
Ventolin
VENTOLIN CR
VENTOLIN E-BREATHE
VENTOLIN HFA
Ventolin inhaler
Ventolin rotacaps
Ventoline
Volare albuterol hfa
Volare easi-breathe
Volma
Volmax
Xopenex
Xopenex HFA
Zaperin
|
|
31 |
|
Oxytocin |
Approved, Vet_approved |
|
|
50-56-6 |
439302 53477758 |
Synonyms:
(2S)-2-[({1-[(4R,7S,10S,13S,16S,19R)-19-amino-13-[(2S)-butan-2-yl]-6,9,12,15,18-pentahydroxy-10-[2-(C-hydroxycarbonimidoyl)ethyl]-7-[(C-hydroxycarbonimidoyl)methyl]-16-[(4-hydroxyphenyl)methyl]-1,2-dithia-5,8,11,14,17-pentaazacycloicosa-5,8,11,14,17-pentaene-4-carbonyl]pyrrolidin-2-yl}(hydroxy)methylidene)amino]-N-[(C-hydroxycarbonimidoyl)methyl]-4-methylpentanimidate
(Arg8)-vasopressin
(Arg8)-vasotocin
[<sup>3</sup>H]oxytocin
alpha-Hypophamine
Argipressin
Argpressin acetate
Biotinyl-(arg8)-vasopressin
Cys-tyr-ile-GLN-asn-cys-pro-arg-gly-NH2
Cys-tyr-ile-GLN-asn-cys-pro-leu-gly-NH2
Cys-tyr-ile-THR-asn-cys-gly-leu-gly-NH2
Cys-tyr-phe-GLN-asn-cys-pro-arg-gly-NH2
Cys-tyr-phe-GLN-asn-cys-pro-lys-gly-NH2
Disulfide bridge cys1-cys6
Gly-leu-pro-c
Ocytocin
|
ORASTHIN
Oxitocina
OXT
OXYTOCIN
Oxytocin 10 usp units in dextrose 5%
Oxytocin 20 usp units in dextrose 5%
Oxytocin 5 usp units in dextrose 5%
Oxytocin acetate
Oxytocin injection
PITOCIN
SID29217903
SID50111741
SYNTOCINON
SYNTOMETRINE
SYT670
TTA-121
|
|
32 |
|
D-Threonine |
Approved, Experimental, Nutraceutical |
|
|
72-19-5, 632-20-2 |
205 6288 |
Synonyms:
(2S)-threonine
(2S,3R)-(-)-Threonine
(2S,3R)-2-Amino-3-hydroxybutanoate
(2S,3R)-2-Amino-3-hydroxybutanoic acid
(2S,3R)-2-Amino-3-hydroxybutyrate
(2S,3R)-2-Amino-3-hydroxybutyric acid
(R-(R*,s*))-2-amino-3-hydroxybutanoate
(R-(R*,s*))-2-amino-3-hydroxybutanoic acid
(S)-Threonine
[R-(R*,s*)]-2-amino-3-hydroxybutanoate
[R-(R*,s*)]-2-amino-3-hydroxy-butanoate
[R-(R*,s*)]-2-amino-3-hydroxybutanoic acid
[R-(R*,s*)]-2-amino-3-hydroxy-butanoic acid
2-Amino-3-hydroxybutanoate
2-Amino-3-hydroxybutanoic acid
2-Amino-3-hydroxybutyrate
2-Amino-3-hydroxybutyric acid
a-Amino-b-hydroxybutyrate
a-Amino-b-hydroxybutyric acid
alpha-Amino-beta-hydroxybutyrate
|
L Threonine
L-(-)-Threonine
L-2-Amino-3-hydroxybutyrate
L-2-Amino-3-hydroxybutyric acid
L-a-Amino-b-hydroxybutyrate
L-a-Amino-b-hydroxybutyric acid
L-alpha-Amino-beta-hydroxybutyrate
L-alpha-amino-beta-hydroxybutyric acid
L-Threonin
L-Threonine
L-Α-amino-β-hydroxybutyrate
L-α-amino-β-hydroxybutyric acid
T
Thr
Threonin
Threonine
Threoninum
Treonina
Α-amino-β-hydroxybutyrate
Α-amino-β-hydroxybutyric acid
|
|
33 |
|
Vasoconstrictor Agents |
|
|
|
|
|
34 |
|
Immunoglobulins |
|
|
|
|
|
35 |
|
Antibodies |
|
|
|
|
|
36 |
|
Liver Extracts |
|
|
|
|
|
Interventional clinical trials:
(show top 50)
(show all 77)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Inhaled Nitric Oxide (iNO) for Congenital Diaphragmatic Hernia (CDH) - The "NoNO Trial" - a Multi-center, De-implementation, Stepped-wedge, Cluster-randomized Trial Within an Established Collaborative |
Not yet recruiting |
NCT05213676 |
Phase 4 |
Inhaled Nitric Oxide (iNO) use |
2 |
Chronic Sildenafil for Severe Diaphragmatic Hernia |
Terminated |
NCT00133679 |
Phase 4 |
sildenafil;Placebo |
3 |
Rectal and Oral Omeprazole Treatment of Gastroesophageal Reflux in Infants With Esophageal Atresia or Congenital Diaphragmatic Hernia; A Pharmacodynamic and Pharmacokinetic Study. |
Completed |
NCT00226044 |
Phase 3 |
Omeprazole rectally 1mg/kg |
4 |
Randomized Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) Versus Expectant Management During Pregnancy in Fetuses With Left Sided and Isolated Congenital Diaphragma Hernia and Severe Pulmonary Hypoplasia. |
Completed |
NCT01240057 |
Phase 2, Phase 3 |
|
5 |
Prospective Randomized Trial Comparing Type of Material in Repair of Congenital Diaphragmatic Hernia |
Terminated |
NCT00257946 |
Phase 3 |
|
6 |
Contribution of PRF (Platelet Rich Fibrin) in the Biological Functionalization of Prothetic Patch Closure : in Vitro Study |
Terminated |
NCT03861182 |
Phase 3 |
|
7 |
"Early" Versus "Standard" Fetal Endoscopic Tracheal Occlusion for Severe Congenital Diaphragmatic Hernia - a Randomized Controlled Trial |
Unknown status |
NCT01731509 |
Phase 2 |
|
8 |
Tracheal Occlusion Guided by Percutaneous Fetoscopy in Fetuses With Severe Isolated Congenital Diaphragmatic Hernia |
Unknown status |
NCT01302977 |
Phase 2 |
|
9 |
Randomized Clinical Trial in Order to Assess the Effect of Fetoscopic Tracheal Balloon Occlusion on the Postnatal Disease Course in Neonates With Left Congenital Diaphragmatic Hernia - FDH-ECMO/BALLOON-TRIAL |
Unknown status |
NCT00373438 |
Phase 2 |
|
10 |
TOTAL TRIAL: Randomized Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) Versus Expectant Management During Pregnancy in Fetuses With Left-Sided and Isolated Congenital Diaphragmatic Hernia and Moderate Pulmonary Hypoplasia |
Completed |
NCT02875860 |
Phase 2 |
|
11 |
Milrinone in Congenital Diaphragmatic Hernia |
Recruiting |
NCT02951130 |
Phase 2 |
Milrinone;Placebo (5% Dextrose) |
12 |
A Trial of Phosphodiesterase-5 Inhibitor in Neonatal Congenital Diaphragmatic Hernia (TOP-CDH) |
Recruiting |
NCT05201144 |
Phase 2 |
Sildenafil Oral Suspension |
13 |
Phase 2 Fetal Tracheal Balloon (IDE G080077) Study in Diaphragmatic Hernia |
Terminated |
NCT00966823 |
Phase 2 |
|
14 |
Umbilical Cord Blood Mononuclear Cells for Hypoxic Neurologic Injury in Infants With Congenital Diaphragmatic Hernia (CDH) |
Recruiting |
NCT03526588 |
Phase 1 |
|
15 |
Qualitative In-depth Interviews With Women and Their Partners Concerning the Acceptability of Fetal Surgery |
Unknown status |
NCT03788122 |
|
|
16 |
Proteomic Analysis of Amniotic Fluid in the Case of Diaphragmatic Hernia: Search for Prognostic Expression Profiles |
Unknown status |
NCT03179371 |
|
|
17 |
Gene Mutations and Rescue in Human Congenital Diaphragmatic Hernia |
Unknown status |
NCT01098929 |
|
|
18 |
the Effect of Different Modes of Mechanical Ventilation on Cerebral Blood Flow During Thoracoscopic Surgeries in Neonates (RCT) |
Unknown status |
NCT04507295 |
|
|
19 |
The Intrauterine Fetoscopic Tracheal Occlusion (FETO) With Long Tail Balloon for a Treatment of Severe Congenital Diaphragmatic Hernia (CDH) |
Unknown status |
NCT03431792 |
|
|
20 |
Optimisation of Neonatal Ventilation: Congenital Diaphragmatic Hernia - Determining the Appropriate Level of Volume Guarantee |
Unknown status |
NCT02849054 |
|
|
21 |
Prospective Data Collection of Patients < 6 Months of Age Undergoing Thoracoscopic Surgery |
Completed |
NCT02033772 |
|
|
22 |
Randomized Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) Versus Expectant Management During Pregnancy in Fetuses With Left Sided and Isolated Congenital Diaphragmatic Hernia and Moderate Pulmonary Hypoplasia. |
Completed |
NCT00763737 |
|
|
23 |
Delayed Cord Clamping for Intubation and Gentle Ventilation in Infants With Congenital Diaphragmatic Hernia |
Completed |
NCT03314233 |
|
|
24 |
Virtual Reality-based Exercises' Effects on Pulmonary Functions, Cardiopulmonary Capacity, Functional Performance, and Quality of Life in Children With Repaired Congenital Diaphragmatic Hernia |
Completed |
NCT05612503 |
|
|
25 |
Determining the Effect of Probiotics on Microbiome and Volatile Organic Compounds in Patients After Surgical Repair of Congenital Diaphragmatic Hernia |
Completed |
NCT03787160 |
|
|
26 |
Management and Outcomes of Congenital Anomalies in Low-, Middle- and High-Income Countries: A Multi-Centre, International, Prospective Cohort Study |
Completed |
NCT03666767 |
|
|
27 |
Resuscitation of Infants With Congenital Diaphragmatic Hernia With an Intact Umbilical Cord |
Completed |
NCT03242044 |
|
|
28 |
Investigation of Airway Inflammation in Congenital Diaphragmatic Hernia Patients |
Completed |
NCT02453750 |
|
Hypersaline;Bronchodilator Response |
29 |
Hypercapnia During Thoracoscopy or Open Surgery for Repair of Oesophageal Atresia With Tracheo-oesophageal Fistula or Congenital Diaphragmatic Hernia in Neonates: Pilot Randomised Controlled Trial |
Completed |
NCT01467245 |
|
|
30 |
Inflammatory Cytokine Quantification in Infants With Documented Sepsis, Congenital Diaphragmatic Hernia and/or ECMO Therapy |
Completed |
NCT01155830 |
|
|
31 |
Physiologic Pilot Study: Work of Breathing Description in Neonates With Congenital Diaphragmatic Hernia in Post-surgical Period Alternatively in Conventional Ventilation (Pressure Controlled) and in NAVA (Neurally Adjusted Ventilatory Assist) Ventilation. |
Completed |
NCT03250793 |
|
|
32 |
Early Childhood Follow-up of Congenital Diaphragmatic Hernia Survivors |
Completed |
NCT01029665 |
|
|
33 |
Effect of Chest Resistance Exercise Combined With Chest Expansion Exercises on Respiratory Muscle Strength, Lung Function, and Thoracic Excursion in Children With Post-operative Congenital Diaphragmatic Hernia |
Completed |
NCT04900649 |
|
|
34 |
Genetic Basis of Non Syndromic Congenital Diaphragmatic Hernia |
Completed |
NCT02175264 |
|
|
35 |
Compare the Effects of Volume-oriented Versus Flow-oriented Incentive Spirometry on Pulmonary Function and Functional Capacity in Patients of Upper Abdominal Laparoscopic Surgery |
Completed |
NCT04716166 |
|
|
36 |
Observational Longitudinal Study in Children With the Diagnosis of Diaphragmatic Hernia and/or Oesophageal Atresia for Assessing Lung Function Parameters and Quality of Life |
Completed |
NCT02466451 |
|
|
37 |
Antibody Secreting Cell (ASC) and Immunoactive Protein Profiles in Neonates on Extracorporeal Membrane Oxygenation (ECMO) |
Completed |
NCT00371241 |
|
|
38 |
Postoperative Outcomes of Trans-abdominal Open Surgical Repair of Traumatic Diaphragmatic Hernias in Adults. |
Completed |
NCT05591482 |
|
|
39 |
Molecular Genetic Analysis of Fraser Syndrome and Fryns Syndrome |
Completed |
NCT00032877 |
|
|
40 |
Effects of Position and a Test Meal on Esophago-gastric Junction Morphology and Function Assessed by High-resolution Impedance Manometry (HRM) |
Completed |
NCT02397616 |
|
|
41 |
True Short Esophagus in Gastroesophageal Reflux Disease or Hiatus Hernia |
Completed |
NCT03848494 |
|
|
42 |
Single Anastomosis Sleeve Iejenal Bypass With Crural Repair in Obese Patient With Hiatus Hernia |
Completed |
NCT04823767 |
|
|
43 |
Frequency of True Short Esophagus in Type II-IV Hiatus Hernia |
Completed |
NCT01587859 |
|
|
44 |
Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Severe Left Congenital Diaphragmatic Hernia (CDH) |
Recruiting |
NCT04583644 |
|
|
45 |
Study of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Fetuses With Severe Left Congenital Diaphragmatic Hernia (CDH) |
Recruiting |
NCT02710968 |
|
|
46 |
Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Severe Left Congenital Diaphragmatic Hernia (CDH) |
Recruiting |
NCT02596802 |
|
|
47 |
ECHO-CDH - Exploratory Observational Prospective Study in Neonatal and Pediatric Congenital Diaphragmatic Hernia |
Recruiting |
NCT04114578 |
|
|
48 |
Feto-Endoscopic Tracheal Occlusion (FETO) for Left Congenital Diaphragmatic Hernia |
Recruiting |
NCT02986087 |
|
|
49 |
The Role of 3D Images and Models to Aid Management of Cases of Congenital Diaphragmatic Hernia Diagnosed in the Antenatal Period. Consecutive Patients Studied From Diagnosis to Post Operative Period. |
Recruiting |
NCT03750266 |
|
|
50 |
Pilot Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) in Severe Right and Left Congenital Diaphragmatic Hernia (CDH) |
Recruiting |
NCT03674372 |
|
|
|